Literature DB >> 22209509

Emergence and risk factors of β-lactamase-mediated resistance to oxyimino-β-lactams in Enterobacteriaceae isolates.

Vera Manageiro1, Eugénia Ferreira, Daniela Jones-Dias, Deolinda Louro, Margarida Pinto, José Diogo, Manuela Caniça.   

Abstract

We studied 193 Enterobacteriaceae isolates presenting diminished susceptibility to oxyimino-cephalosporins recovered in a Portuguese hospital (2004-2008). CTX-M-3 producers, firstly detected in Portugal, were associated with a Klebsiella pneumoniae microepidemic clone. Production of CTX-M-type enzymes (CTX-M-1/-3/-9/-14/-15/-32), age ≥65 years, and nosocomial infection were risk factors for higher nonsusceptibility to oxyimino-β-lactams. CMY-2 and DHA-1 β-lactamases were only identified in 1% of isolates.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209509     DOI: 10.1016/j.diagmicrobio.2011.11.009

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  4 in total

1.  Diversity of extended-spectrum and plasmid-mediated AmpC β-lactamases in Enterobacteriaceae isolates from Portuguese health care facilities.

Authors:  Daniela Jones-Dias; Vera Manageiro; Eugénia Ferreira; Deolinda Louro; Manuela Caniça
Journal:  J Microbiol       Date:  2014-05-29       Impact factor: 3.422

Review 2.  Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses.

Authors:  Tirza C Hendrik; Anne F Voor In 't Holt; Margreet C Vos
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

3.  Molecular characterization of ESBL-producing Enterobacteriaceae in northern Portugal.

Authors:  Rúben Fernandes; Paula Amador; Carla Oliveira; Cristina Prudêncio
Journal:  ScientificWorldJournal       Date:  2014-02-13

4.  CTX-M-15-Producing Escherichia coli in Dolphin, Portugal.

Authors:  Vera Manageiro; Lurdes Clemente; Daniela Jones-Dias; Teresa Albuquerque; Eugénia Ferreira; Manuela Caniça
Journal:  Emerg Infect Dis       Date:  2015-12       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.